Literature DB >> 22262758

Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche.

Elodie Belnoue1, Chantal Tougne, Anne-Françoise Rochat, Paul-Henri Lambert, Daniel D Pinschewer, Claire-Anne Siegrist.   

Abstract

According to commonly held concepts, plasma cell (PC) longevity in bone marrow (BM) depends upon their access to survival niches. These are thought to exist in nursery cell types, which support PCs by secreting PC survival factors. To better define PC survival niches and their functioning, we adoptively transferred traceable Blimp-1-(GFP) PCs into recipient mice lacking a proliferation-inducing ligand (APRIL), IL-6, or macrophage migration inhibitory factor. Transferred BMPCs were preferentially associated with Ly-6C(high) monocytes (normalized colocalization index: 9.84), eosinophils (4.29), and megakaryocytes (2.12). Although APRIL was essential for BMPC survival, PC recruitment into the proximity of nursery cells was unimpaired in APRIL-deficient mice, questioning the concept that the same factors account for attraction/retention of PCs as for their local survival. Rather, the order of colocalization with BMPCs (monocytes > eosinophils > megakaryocytes) reflected these cells' relative expression of CXCR4, VLA-4, and LFA-1, the homing and adhesion molecules that direct/retain PCs in the BM. This suggests a scenario wherein the cellular composition of the BMPC niche is defined by a common pattern of attraction/retention on CXCL12-abundant reticular docking cells. Thereby, PCs are directed to associate in a functional BM niche with hematopoietic CXCR4(+)VLA-4(+)LFA-1(+) nursery cells, which provide PC survival factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262758     DOI: 10.4049/jimmunol.1103169

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  [Stromal cells as coordinators of adaptive immune response and immunological memory].

Authors:  A E Hauser
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

Review 2.  Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche.

Authors:  Joel R Wilmore; David Allman
Journal:  J Immunol       Date:  2017-08-01       Impact factor: 5.422

3.  Automated quantification of hematopoietic cell - stromal cell interactions in histological images of undecalcified bone.

Authors:  Sandra Zehentmeier; Zoltan Cseresnyes; Juan Escribano Navarro; Raluca A Niesner; Anja E Hauser
Journal:  J Vis Exp       Date:  2015-04-08       Impact factor: 1.355

4.  IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.

Authors:  M Jourdan; M Cren; N Robert; K Bolloré; T Fest; C Duperray; F Guilloton; D Hose; K Tarte; B Klein
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

5.  Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners.

Authors:  Robert E Sealy; Sherri L Surman; Peter Vogel; Julia L Hurwitz
Journal:  Int Immunol       Date:  2016-07-18       Impact factor: 4.823

6.  Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.

Authors:  Haoyang Zhuang; Shuhong Han; Yuan Xu; Yi Li; Hai Wang; Li-Jun Yang; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

7.  Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals.

Authors:  Jairo M Montezuma-Rusca; Susan Moir; Lela Kardava; Clarisa M Buckner; Aaron Louie; Leo J Y Kim; Brian H Santich; Wei Wang; Olivia R Fankuchen; Gabriella Diaz; Janine R Daub; Sergio D Rosenzweig; Tae-Wook Chun; Yuxing Li; Raul C Braylan; Katherine R Calvo; Anthony S Fauci
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

Review 8.  Niches for Hematopoietic Stem Cells and Their Progeny.

Authors:  Qiaozhi Wei; Paul S Frenette
Journal:  Immunity       Date:  2018-04-17       Impact factor: 31.745

Review 9.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

Review 10.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.